Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Kingman. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Kingman at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this ovarian cancer clinical trial in Kingman, AZ
If you're searching for ovarian cancer treatment options in Kingman, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kingman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.